Clinical trial
Study of Breast Cancer Prevention by Letrozole in High Risk Women
NCT00579826 is registered in ClinicalTrials.gov with Carol Fabian, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Breast Cancer Prevention by Letrozole in High Risk Women
- Lead sponsor
- Carol Fabian, MD
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2006
- Completion date
- August 31, 2018
- Enrollment
- 55 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer